MERIDIAN RESEARCH

🧭 MACRO SNAPSHOT

The tape continues to grind higher with the S&P at 7,398.93 and VIX at 17.08 (source: FRED), but the macro backdrop is increasingly bifurcated. The Fed funds rate sits at 3.64% with the 2s/10s curve at +49 bps (3.92% / 4.41%, source: FRED) — a normal, mildly steepening curve consistent with the soft-landing narrative the market has now fully embraced. Unemployment at 4.3% and GDP growth at 2.0% are non-recessionary but soft enough to keep the Fed in cutting posture. HY credit spreads at 279 bps are tight but not euphoric. None of this argues for chasing risk; it argues for selectivity.

The more important signal today is in the macro headlines: the Iran war is now materially distorting commodity flows — global oil buffer drainage (Bloomberg), sulfuric acid shortages ("world's most used chemical," WSJ), and disruptions to Asian agriculture (WaPo). This matters for the portfolio in two ways: (1) energy and refined-product names like XOM and OKE have a structurally tighter supply backdrop than the current price action reflects (XOM -5.9% on the week despite this — source: yfinance), and (2) the chemical and fertilizer disruption is a tail-risk to global industrial production that could hit cyclical names in H2. Trump's "I expected oil to hit $200" comment is a useful reminder that this geopolitical premium is real, not narrative. I'm not chasing energy here, but the bear case on XOM has weakened.

₿ BITCOIN UPDATE

Action: STRONG HOLD | Conviction: 9/10

BTC at $81,069 (+0.37% 24h, +2.91% 7d, +10.88% 30d) with dominance at 58.1%. No structural changes this week — we remain ~12-13 months post-halving, squarely in the historical late-stage kinetic window of the 4-year cycle. The 30-day move is constructive without being euphoric, and the lack of dominance erosion suggests this is institutional/spot-driven rather than alt-speculation. Thesis fully intact: scarce, programmable, monetary asset in a fiat regime with structurally elevated deficits and a Fed in cutting mode. Continue to hold.

🔬 TODAY'S DEEP DIVES

FTNT — Fortinet, Inc. — ROLLING REVIEW

Conviction: 6/10 | Status: MONITORING | Sector: Cybersecurity

WHAT THEY DO: Fortinet sells integrated network security — firewalls, SD-WAN, SASE (cloud-delivered security), and OT/industrial security — anchored by their proprietary FortiOS operating system running on custom FortiASIC silicon. Unlike competitors who run security functions on general-purpose Intel/AMD chips, Fortinet's ASIC approach delivers more security throughput per dollar, which historically translated into best-in-class gross margins (80.3% TTM, source: yfinance) and pricing flexibility. They sell hardware + recurring software/subscription bundles to enterprises and service providers globally.

WHY IT'S INTERESTING NOW: Q1 2026 earnings (released 2026-05-07) showed profits +23% with raised full-year guidance — the 2023-24 firewall digestion cycle is decisively over and a refresh wave is underway. The stock has re-rated +48.7% in one month and +27.8% in one week (source: yfinance), confirming the market is now pricing the inflection rather than questioning it. The question is no longer "is the business accelerating" but "is it accelerating enough to justify the new multiple."

BULL CASE:

• Secular tailwind intact: cybersecurity spend compounds at 12-15% (Gartner/IDC), with SASE and OT growing 25%+ — Fortinet plays in all of it.
• ASIC moat = structural margin advantage that competitors using commodity silicon cannot replicate without billions in R&D and multi-year design cycles.
• Q1 reacceleration (+20.1% TTM revenue growth, source: yfinance) suggests the refresh cycle is real, not a one-quarter blip.
• Multi-product platform consolidation favors Fortinet over single-product point-solution vendors (CRWD, ZS) in budget-constrained environments.

BEAR CASE:

• Valuation is now demanding: P/E 44x, EV/EBITDA 34x, P/S 11.7x (source: yfinance). Stock trades above the consensus PT of $105.50 with a "Hold" rating from 36 analysts (source: yfinance).
• Forward P/E of 33x prices in flawless multi-year execution.
• Firewall refresh cycles are inherently lumpy — 2027 could see another digestion period.
• The +48.7% one-month move is the kind of crowd-following price action I'm explicitly skeptical of.

KEY METRICS: Revenue growth 20.1% TTM | Gross margin 80.3% | P/E 44x | EV/EBITDA 34x | Differentiator: only major cyber vendor with custom ASIC silicon (source: yfinance + company disclosures).

BOTTOM LINE: FTNT belongs on the list at 6/10 conviction — the fundamentals justify ownership but valuation post-rally requires a pullback before I move to RECOMMEND.

FTNT — Fortinet, Inc. — NEW IDEA (Initiation)

Conviction: 6/10 | Status: MONITORING | Sector: Cybersecurity

Same name as above — this was today's initiation and rolling review concurrently because it just earned a target list spot via screening. See deep dive above; conclusion is unchanged at 6/10 monitoring. The dual entry reflects the workflow (screener + rolling review hit simultaneously) rather than two separate analytical views.

SMAR — Smartsheet Inc. — NEW IDEA

Conviction: 3/10 | Status: WATCHLIST (NOT ADDED) | Sector: Enterprise SaaS

WHAT THEY DO: Smartsheet is a cloud-based collaborative work management (CWM) platform — think a spreadsheet-meets-project-management tool used by enterprise teams to coordinate workflows, automate processes, and track work across departments. They sell per-seat subscriptions to enterprises, with significant penetration into the Fortune 500.

WHY IT'S INTERESTING NOW: Honestly — it isn't, for our purposes. Smartsheet announced in September 2024 that it agreed to be taken private by Blackstone/Vista at $56.50/share cash. This is no longer a public equity investment thesis; it's a merger-arb situation. Critical data integrity flag: the data feed returned null values across virtually every fundamental field for this name, so I will not fabricate metrics.

BULL CASE:

• Deal closes at $56.50 cash — defined return, primary risk is regulatory approval.
• Underlying CWM TAM (>$10B by 2026 per Gartner) and historically strong net revenue retention demonstrate genuine product stickiness.

BEAR CASE:

• The deal closes and the security ceases to trade — there is no 3-5 year compounding thesis here. This is the most likely outcome and is disqualifying for our mandate.
• Deal breaks (regulatory/financing/MAC) → stock retraces 20-35% to pre-announcement levels.

KEY METRICS: Not reliably available in today's pull — flagging as a data gap.

BOTTOM LINE: SMAR does not belong on the target list. We're long-horizon equity investors, not merger-arb traders. Action: SCREENED, NOT ADDED.

📋 TARGET LIST STATUS

Conviction changes this week: No upgrades or downgrades to existing names today — FTNT was the only new addition, displacing nothing (we have headroom on the 50-name cap). The notable moves on the tape — MU +29.5%/1W, AMD +33.3%/1W, FTNT +27.8%/1W — are price action without thesis changes; I am explicitly not chasing.

Names dropped: None today. SMAR was screened and rejected due to pending take-private deal (not an equity vehicle for a 3-5 year hold).

💼 YOUR PORTFOLIO

• AAPL — 200 sh @ $50.46 | HOLD | 8/10. +481% unrealized gain on a foundational compounder; ecosystem moat and services mix continue to underpin valuation.
• BABA — 40 sh @ $127.86 | HOLD | 8/10. +9.5% in position; Chinese AI/cloud story regaining traction with cleaner regulatory backdrop than 2022-23.
• FSLR — 10 sh @ $186.18 | HOLD | 8/10. +18% unrealized; best-in-class U.S. solar manufacturer with IRA/domestic-content tailwind intact.
• GOOGL — 32 sh @ $320.20 | STRONG HOLD | 9/10. +25% unrealized; Gemini/Search/Cloud all firing, AI distribution moat remains underappreciated.
• ISRG — 5 sh @ $578.24 | HOLD | 7/10. -22% unrealized; surgical robotics franchise intact, but valuation re-rating has been painful. Thesis unchanged.
• MKL — 13 sh @ $909.50 | HOLD | 7/10. +99.5% unrealized; Markel's insurance + investment model continues to compound book value steadily.
• TSLA — 83 sh @ $419.09 | HOLD | 5/10. +2% unrealized after recent recovery; auto decel concerns persist, robotics/FSD optionality keeps it from being a sell.
• UNH — 15 sh @ $314.29 | HOLD | 6/10. +20.9% unrealized; managed care headwinds priced in, but visibility remains limited. Watching for catalyst clarity.
• AVAV, AVGO, MP, SYM, BTC (1 sh) — Pending position analyses; will be refreshed on next run.

⚠️ WATCH LIST

• FTNT — Upgrade trigger to 7/10 RECOMMEND requires either (a) a 15-20% pullback to bring forward P/E back near 28x, or (b) another quarter of >20% revenue growth confirming the refresh cycle has legs into 2027.
• NVDA — Holding 8/10 but the +8.4% weekly move is heating up. Watching hyperscaler capex commentary in Q2 earnings season — any sign of digestion would warrant a downgrade given $5T+ market cap.
• HUBS — Down 20.2% in a week with no fundamental data point to explain it (only headlines reference Cybertruck recalls and Breeze AI). Need to dig in — could be a setup or could be a Datadog-style positive surprise inverse. Monitoring closely.
• XOM — Iran-driven oil supply tightness arguing for upgrade consideration, but stock is down 5.9% on the week, suggesting market doesn't yet believe the premium will hold. Need Q2 capex/production guidance before moving.
• MU — +77.5% one-month move is exactly the kind of crowd consensus I'm skeptical of. If HBM pricing data softens at all in next earnings, downgrade catalyst is in place.